Cypress Wealth Services, LLC

Position in GSK — GSK plc

CIK 1721527 PALM DESERT, CA

Position in GSK

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$610,693

-$39,003 QoQ

Shares Held

11,650

-1.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#439

of 1,033 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cypress Wealth Services, LLC holds $11,046,783 across 9 Drug Manufacturers - General names. GSK ranks #6 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,396	$2,873,834
2	JNJ	Johnson & Johnson	10,579	$2,686,748
3	MRK	Merck & Co., Inc.	13,738	$1,765,333
4	ABBV	AbbVie Inc.	4,720	$1,187,740
5	AMGN	Amgen Inc	2,114	$765,521
6	GSK	GSK plc This page	11,650	$610,693
7	PFE	Pfizer Inc	19,074	$459,301
8	AZN	Astrazeneca PLC	2,069	$392,323

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$610,693	11,650	-1.0%	Shares	Sole	2026-07-13
2026-03-31	$649,696	11,772	-0.2%	Shares	Sole	2026-04-15
2025-12-31	$578,328	11,793	+1.3%	Shares	Sole	2026-01-14
2025-09-30	$502,468	11,642	+0.5%	Shares	Sole	2025-10-15
2025-06-30	$445,017	11,589	+1.3%	Shares	Sole	2025-07-28
2025-03-31	$443,340	11,444	-4.4%	Shares	Sole	2025-04-10
2024-12-31	$404,690	11,966	+23.8%	Shares	Sole	2025-01-15
2024-09-30	$395,105	9,665	+1.1%	Shares	Sole	2024-10-09
2024-06-30	$368,060	9,560	+1.4%	Shares	Sole	2024-07-12
2024-03-31	$404,264	9,430	0.0%	Shares	Sole	2024-04-16
2023-12-31	$349,475	9,430	-2.2%	Shares	Sole	2024-01-11
2023-09-30	$349,377	9,638	—	Shares	Sole	2023-10-13
No filing history on record for this holder in this stock.